These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15914104)

  • 1. Divergent roles of endothelial nitric oxide synthase in cardiac hypertrophy and chamber dilatation?
    Shah AM
    Cardiovasc Res; 2005 Jun; 66(3):421-2. PubMed ID: 15914104
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
    Li YS; Wang ZH; Yan L; Yong YQ; Wang J; Liang QS; Zheng Z; Yang GT
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1446-50. PubMed ID: 18837353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac hypertrophy and ventricular remodeling.
    Anversa P; Capasso JM
    Lab Invest; 1991 Apr; 64(4):441-5. PubMed ID: 1826750
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of myocardial cell necrosis with experimental cardiac hypertrophy.
    Revis NW; Cameron AJ
    J Pathol; 1979 Aug; 128(4):193-202. PubMed ID: 160447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK1 is required to preserve cardiac function in the early response to pressure overload.
    Tachibana H; Perrino C; Takaoka H; Davis RJ; Naga Prasad SV; Rockman HA
    Biochem Biophys Res Commun; 2006 May; 343(4):1060-6. PubMed ID: 16579967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells.
    Müller P; Kazakov A; Semenov A; Böhm M; Laufs U
    Cardiovasc Res; 2008 Jan; 77(1):151-9. PubMed ID: 18006457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive nitric oxide synthases in the heart from hypertrophy to failure.
    Loyer X; Heymes C; Samuel JL
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):483-8. PubMed ID: 18307746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.
    Saraiva RM; Minhas KM; Raju SV; Barouch LA; Pitz E; Schuleri KH; Vandegaer K; Li D; Hare JM
    Circulation; 2005 Nov; 112(22):3415-22. PubMed ID: 16301341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL; Yin H; Huang J
    Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable left ventricular hypertrophy in the dog. Experiental production, time course, and natural history.
    O'Kane HO; Geha AS; Kleiger RE; Abe T; Salaymeh MT; Malik AB
    J Thorac Cardiovasc Surg; 1973 Feb; 65(2):264-71. PubMed ID: 4265344
    [No Abstract]   [Full Text] [Related]  

  • 13. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways.
    Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features of the papillary trabecular apparatus of the cardiac ventricles under normal conditions and in hypertrophy].
    Galankin VN
    Arkh Patol; 1972; 34(9):30-5. PubMed ID: 4264807
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The muscle-collagen ratio in left ventricular hypertrophy and aorta remodelling in hypertension.
    Rossi MA
    Acta Physiol (Oxf); 2008 Sep; 194(1):1-2. PubMed ID: 18694419
    [No Abstract]   [Full Text] [Related]  

  • 17. ["Size of the heart" from pathological viewpoint--some pathological problems on cardiac hypertrophy and dilatation (author's transl)].
    Imai M
    Kokyu To Junkan; 1981 Mar; 29(3):275-85. PubMed ID: 6454951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiologic and pathologic left ventricular hypertrophy].
    Corea L; Bentivoglio M; Buccolieri M; Savino K
    Cardiologia; 1991 Jan; 36(1):71-80. PubMed ID: 1831689
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
    Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
    J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.